Hemostatic drug less effective than originally predicted
Monday, November 15, 2010 - 13:30
in Health & Medicine
The use of recombinant activated factor 7 -- a drug used to treat bleeding in hemophiliacs -- in patients without hemophilia is not recommended because of the potential for adverse events, found a new study.